- Home
- LGVN vs CXAI Comparison
LGVN vs CXAI Comparison
Compare LGVN & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- CXAI
- Stock Information
- Founded
- LGVN 2014
- CXAI N/A
- Country
- LGVN United States
- CXAI United States
- Employees
- LGVN N/A
- CXAI N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- CXAI EDP Services
- Sector
- LGVN Health Care
- CXAI Technology
- Exchange
- LGVN Nasdaq
- CXAI Nasdaq
- Market Cap
- LGVN 17.6M
- CXAI 17.8M
- IPO Year
- LGVN 2021
- CXAI N/A
- Fundamental
- Price
- LGVN $0.63
- CXAI $0.45
- Analyst Decision
- LGVN Strong Buy
- CXAI
- Analyst Count
- LGVN 2
- CXAI 0
- Target Price
- LGVN $6.50
- CXAI N/A
- AVG Volume (30 Days)
- LGVN 388.1K
- CXAI 761.7K
- Earning Date
- LGVN 11-04-2025
- CXAI 11-12-2025
- Dividend Yield
- LGVN N/A
- CXAI N/A
- EPS Growth
- LGVN N/A
- CXAI N/A
- EPS
- LGVN N/A
- CXAI N/A
- Revenue
- LGVN $1,437,000.00
- CXAI $5,222,000.00
- Revenue This Year
- LGVN N/A
- CXAI N/A
- Revenue Next Year
- LGVN N/A
- CXAI $60.00
- P/E Ratio
- LGVN N/A
- CXAI N/A
- Revenue Growth
- LGVN N/A
- CXAI N/A
- 52 Week Low
- LGVN $0.59
- CXAI $0.39
- 52 Week High
- LGVN $2.24
- CXAI $2.54
- Technical
- Relative Strength Index (RSI)
- LGVN 30.36
- CXAI 31.02
- Support Level
- LGVN $0.59
- CXAI $0.39
- Resistance Level
- LGVN $0.67
- CXAI $0.49
- Average True Range (ATR)
- LGVN 0.05
- CXAI 0.05
- MACD
- LGVN -0.01
- CXAI -0.01
- Stochastic Oscillator
- LGVN 16.06
- CXAI 23.11
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.